NovaBay Pharmaceuticals Inc banner
N

NovaBay Pharmaceuticals Inc
AMEX:SDEV

Watchlist Manager
NovaBay Pharmaceuticals Inc
AMEX:SDEV
Watchlist
Price: 1.65 USD 15.38% Market Closed
Market Cap: $43.9m

Wall St Price Targets

SDEV Price Targets Summary
NovaBay Pharmaceuticals Inc

There are no price targets for SDEV.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
NovaBay Pharmaceuticals Inc Competitors:
Price Targets
LE
Lands End Inc
195% Upside

Revenue
Forecast

-1% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
-1% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 2 years is 29%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SDEV's stock price target?
Not Available

SDEV does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for NovaBay Pharmaceuticals Inc?
Projected CAGR
29%

Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 2 years is 29%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett